UniProt ID | FBXL2_HUMAN | |
---|---|---|
UniProt AC | Q9UKC9 | |
Protein Name | F-box/LRR-repeat protein 2 {ECO:0000305} | |
Gene Name | FBXL2 {ECO:0000312|HGNC:HGNC:13598} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 423 | |
Subcellular Localization |
Membrane Lipid-anchor . |
|
Protein Description | Calcium-activated substrate recognition component of the SCF (SKP1-cullin-F-box protein) E3 ubiquitin-protein ligase complex, SCF(FBXL2), which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Unlike many F-box proteins, FBXL2 does not seem to target phosphodegron within its substrates but rather calmodulin-binding motifs and is thereby antagonized by calmodulin. This is the case for the cyclins CCND2 and CCND3 which polyubiquitination and subsequent degradation are inhibited by calmodulin. Through CCND2 and CCND3 degradation induces cell-cycle arrest in G(0). [PubMed: 22020328] | |
Protein Sequence | MVFSNNDEGLINKKLPKELLLRIFSFLDIVTLCRCAQISKAWNILALDGSNWQRIDLFNFQTDVEGRVVENISKRCGGFLRKLSLRGCIGVGDSSLKTFAQNCRNIEHLNLNGCTKITDSTCYSLSRFCSKLKHLDLTSCVSITNSSLKGISEGCRNLEYLNLSWCDQITKDGIEALVRGCRGLKALLLRGCTQLEDEALKHIQNYCHELVSLNLQSCSRITDEGVVQICRGCHRLQALCLSGCSNLTDASLTALGLNCPRLQILEAARCSHLTDAGFTLLARNCHELEKMDLEECILITDSTLIQLSIHCPKLQALSLSHCELITDDGILHLSNSTCGHERLRVLELDNCLLITDVALEHLENCRGLERLELYDCQQVTRAGIKRMRAQLPHVKVHAYFAPVTPPTAVAGSGQRLCRCCVIL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MVFSNNDEGLI ----CCCCCCCCCCC | 24.26 | 25159151 | |
13 | Ubiquitination | NDEGLINKKLPKELL CCCCCCCCCCCHHHH | 49.01 | 29967540 | |
74 | Ubiquitination | RVVENISKRCGGFLR CHHCHHHHHCCHHHH | 48.16 | - | |
84 | Phosphorylation | GGFLRKLSLRGCIGV CHHHHHCCCCCCCCC | 21.03 | 24719451 | |
201 | Ubiquitination | QLEDEALKHIQNYCH CCHHHHHHHHHHHHH | 45.79 | - | |
326 | Phosphorylation | LSHCELITDDGILHL CCCCEEECCCCEEEC | 40.43 | 30576142 | |
334 | Phosphorylation | DDGILHLSNSTCGHE CCCEEECCCCCCCCC | 20.27 | 30576142 | |
399 | Phosphorylation | PHVKVHAYFAPVTPP CCCEEEEEECCCCCC | 5.84 | 23403867 | |
404 | Phosphorylation | HAYFAPVTPPTAVAG EEEECCCCCCCCCCC | 23.61 | 30266825 | |
407 | Phosphorylation | FAPVTPPTAVAGSGQ ECCCCCCCCCCCCCC | 34.66 | 23403867 | |
412 | Phosphorylation | PPTAVAGSGQRLCRC CCCCCCCCCCEEEEE | 23.24 | 23403867 | |
420 | Geranylgeranylation | GQRLCRCCVIL---- CCEEEEEEEEC---- | 0.80 | 15893726 | |
420 | Geranylgeranylation | GQRLCRCCVIL---- CCEEEEEEEEC---- | 0.80 | 15893726 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FBXL2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FBXL2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBXL2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SKP1_HUMAN | SKP1 | physical | 22399757 | |
CUL1_HUMAN | CUL1 | physical | 22399757 | |
A4_HUMAN | APP | physical | 22399757 | |
SKP1_HUMAN | SKP1 | physical | 10508920 | |
CCND2_HUMAN | CCND2 | physical | 22323446 | |
AURKB_HUMAN | AURKB | physical | 23370391 | |
P85A_HUMAN | PIK3R1 | physical | 23604317 | |
P85B_HUMAN | PIK3R2 | physical | 23604317 | |
SKP1_HUMAN | SKP1 | physical | 23604317 | |
CUL2_HUMAN | CUL2 | physical | 23604317 | |
UB2R1_HUMAN | CDC34 | physical | 23604317 | |
UB2D3_HUMAN | UBE2D3 | physical | 23604317 | |
PTN13_HUMAN | PTPN13 | physical | 23604317 | |
PGTB2_HUMAN | RABGGTB | physical | 24035498 | |
NLRP3_HUMAN | NLRP3 | physical | 26037928 | |
UB2D1_HUMAN | UBE2D1 | physical | 26037928 | |
UB2G1_HUMAN | UBE2G1 | physical | 26037928 | |
FOXM1_HUMAN | FOXM1 | physical | 26790640 | |
SKP1_HUMAN | SKP1 | physical | 26790640 | |
CUL1_HUMAN | CUL1 | physical | 26790640 | |
ITPR3_HUMAN | ITPR3 | physical | 28614300 | |
SKP1_HUMAN | SKP1 | physical | 28614300 | |
CUL1_HUMAN | CUL1 | physical | 28614300 | |
TERA_HUMAN | VCP | physical | 28614300 | |
FBX3_HUMAN | FBXO3 | physical | 27010866 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...